ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

ZYNE Zynerba Pharmaceuticals Inc

1.30
0.00 (0.00%)
17 Jun 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Zynerba Pharmaceuticals Inc ZYNE NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 1.30 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.30 1.30
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/2/202418:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/10/202315:48EDGAR2Form 15-12G - Securities registration termination [Section..
11/10/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
11/10/202309:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202309:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202309:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202309:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202308:27EDGAR2Form POS AM - Post-Effective amendments for registration..
11/10/202308:27EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/10/202307:56EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
11/10/202307:31EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/10/202307:17EDGAR2Form 8-K - Current report
11/10/202307:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
04/10/202316:29EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
04/10/202315:05GLOBEImportant Information for Zynerba Pharmaceuticals..
29/9/202308:00GLOBEZynerba Pharmaceuticals Stockholders Reminded to Tender..
27/9/202307:25EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/9/202307:12EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
27/9/202307:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
15/9/202307:00EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202315:59EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
14/9/202315:16EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
14/9/202315:15GLOBEZynerba Pharmaceuticals Presents Positive Data from Phase 2..
14/9/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202315:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202315:39EDGAR2Form SC 13G - Statement of acquisition of beneficial..
29/8/202315:05EDGAR2Form 8-K - Current report
28/8/202308:05EDGAR2Form SC 14D9 - Solicitation, recommendation statements
28/8/202307:23EDGAR2Form SC TO-T - Tender offer statement by Third Party
24/8/202316:23EDGAR2Form SC 13D - General statement of acquisition of beneficial..
15/8/202315:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/8/202316:29EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202316:26EDGAR2Form SC TO-C - Written communication relating to an issuer..
14/8/202316:20EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202306:45EDGAR2Form SC14D9C - Written communication relating to third party..
14/8/202306:42EDGAR2Form 8-K - Current report
14/8/202306:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202306:30PRNUSHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
08/8/202315:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/8/202315:05GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
25/7/202316:24EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
25/7/202316:18GLOBEZynerba Pharmaceuticals Announces New Date for Reconvened..
28/6/202315:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28/6/202315:05GLOBEZynerba Pharmaceuticals Announces Further Adjournment of..
20/6/202306:00GLOBEZynerba Pharmaceuticals to Present at the H.C. Wainwright..

Su Consulta Reciente

Delayed Upgrade Clock